This is a Validated Antibody Database (VAD) review about rat Rnf31, based on 4 published articles (read how Labome selects the articles), using Rnf31 antibody in all methods. It is aimed to help Labome visitors find the most suited Rnf31 antibody. Please note the number of articles fluctuates since newly identified citations are added and citations for discontinued catalog numbers are removed regularly.
MilliporeSigma
domestic rabbit polyclonal
  • western blot; human; 1:1000; loading ...; fig 2a, 2b
MilliporeSigma Rnf31 antibody (Sigma, SAB2102031) was used in western blot on human samples at 1:1000 (fig 2a, 2b). EMBO Mol Med (2022) ncbi
domestic rabbit polyclonal
  • western blot; human; 1:1000; fig s15
MilliporeSigma Rnf31 antibody (Sigma, SAB2102031) was used in western blot on human samples at 1:1000 (fig s15). Nat Commun (2016) ncbi
domestic rabbit polyclonal
  • western blot; human; fig 5
MilliporeSigma Rnf31 antibody (Sigma, SAB2102031) was used in western blot on human samples (fig 5). EMBO J (2016) ncbi
domestic rabbit polyclonal
MilliporeSigma Rnf31 antibody (Sigma, SAB2102031) was used . Am J Hum Genet (2015) ncbi
Articles Reviewed
  1. Zinngrebe J, Moepps B, Monecke T, Gierschik P, Schlichtig F, Barth T, et al. Compound heterozygous variants in OTULIN are associated with fulminant atypical late-onset ORAS. EMBO Mol Med. 2022;14:e14901 pubmed publisher
  2. Nakazawa S, Oikawa D, Ishii R, Ayaki T, Takahashi H, Takeda H, et al. Linear ubiquitination is involved in the pathogenesis of optineurin-associated amyotrophic lateral sclerosis. Nat Commun. 2016;7:12547 pubmed publisher
  3. Wagner S, Satpathy S, Beli P, Choudhary C. SPATA2 links CYLD to the TNF-? receptor signaling complex and modulates the receptor signaling outcomes. EMBO J. 2016;35:1868-84 pubmed publisher
  4. Lewis M, Vyse S, Shields A, Boeltz S, Gordon P, Spector T, et al. UBE2L3 polymorphism amplifies NF-κB activation and promotes plasma cell development, linking linear ubiquitination to multiple autoimmune diseases. Am J Hum Genet. 2015;96:221-34 pubmed publisher